Eisai
4523.T
#2154
Rank
ยฃ6.70 B
Marketcap
ยฃ23.75
Share price
3.73%
Change (1 day)
9.43%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : ยฃ2.46 Billion

According to Eisai's latest financial reports the company's total liabilities are ยฃ2.46 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31ยฃ2.68 B-8.09%
2022-03-31ยฃ2.91 B22.47%
2021-03-31ยฃ2.38 B-11.22%
2020-03-31ยฃ2.68 B-7.6%
2019-03-31ยฃ2.90 B-0.41%
2018-03-31ยฃ2.91 B-4.58%
2017-03-31ยฃ3.05 B24.15%
2016-03-31ยฃ2.46 B-3.08%
2015-03-31ยฃ2.53 B-2.06%
2014-03-31ยฃ2.59 B-28.03%
2013-03-31ยฃ3.60 B-17.87%
2012-03-31ยฃ4.38 B-8.07%
2011-03-31ยฃ4.76 B0.29%
2010-03-31ยฃ4.75 B-4.81%
2009-03-31ยฃ4.99 B49.55%
2008-03-31ยฃ3.34 B236.59%
2007-03-31ยฃ0.99 B-11.4%
2006-03-31ยฃ1.12 B11.35%
2005-03-31ยฃ1.00 B-0.85%
2004-03-31ยฃ1.01 B-7.23%
2003-03-31ยฃ1.09 B11.51%
2002-03-31ยฃ0.98 B-13.64%
2001-03-31ยฃ1.13 B